THURSDAY, June 27, 2024 (HealthDay News) — As psilocybin mushrooms become the most popular psychedelic in the United States, some states have started to ease regulations on its recreational use. Now, a new report warns that the federal government will have to decide whether to follow suit. RAND, a nonprofitContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — A new slow-release pill form of ketamine can quell hard-to-treat depression without producing psychedelic side effects normally associated with the drug, early research suggests. Patients on the strongest dose of ketamine tablets saw significant improvement in their depression compared to a placebo, researchersContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — As scorching summer temperatures drive Americans indoors and millions travel for vacations and family gatherings, COVID infections are again climbing, U.S. health officials warned Monday. In evidence that suggests a COVID summer wave is underway, case counts are most likely increasing in 39 states andContinue Reading
TUESDAY, June 25, 2024 (HealthDay News) — For decades, millions of Americans popped a low-dose aspirin each day to lower their heart risks. Then, accumulated data prompted the nation’s two leading cardiology groups — the American College of Cardiology and the American Heart Association — to overturn advisories in 2019Continue Reading
MONDAY, June 24, 2024 (HealthDay News) — The U.S. Food and Drug Administration’s decision to authorize the first menthol-flavored e-cigarettes has drawn the the ire of health advocates who say the decision undermines efforts to end the youth vaping epidemic in America. In its approval of four flavored vaping productsContinue Reading
WEDNESDAY, June 19, 2024 (HealthDay News) — Only a third of outpatient mental health facilities offer medications essential for treating opioid addiction, a new study finds. Standard care for treating people with opioid use disorder involves drugs like buprenorphine, methadone and naltrexone, which help suppress cravings and blunt the effectsContinue Reading
TUESDAY, June 18, 2024 (HealthDay News) — As marijuana use becomes legal and more accepted across America, more seniors are developing unhealthy relationships with the drug, a new report suggests. A look at data on almost 56 million Medicare beneficiaries finds “rates of health care encounters with cannabis-related disorders increasedContinue Reading
MONDAY, June 17, 2024 (HealthDay News) — Nicotine pouches might be less harmful than smoking or chewing tobacco, but they still pose an addiction risk to users, a new review finds. These pouches are filled with crystallized nicotine, and are placed between the gums and lips, researchers said. They areContinue Reading
MONDAY, June 17, 2024 (HealthDay News) — Opioid overdoses in pregnant women are at an all-time high in the United States, and researchers think they’ve figured out one way to counter this phenomenon. Attention deficit-hyperactivity disorder (ADHD) is strongly tied to substance use disorders, which means some women who becomeContinue Reading
SUNDAY, June 16, 2024 (HealthDay News) — Exploring Europe, taking an African safari, going on a trip to the tropics: In many cases, vaccines are needed for travel, and that’s doubly true for children. According to pediatrician Dr. Lauren Nguyen, researching what vaccines are needed and preparing well before your family’sContinue Reading
FRIDAY, June 14, 2024 (HealthDay News) — COVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot of the JN.1 variant that spread widely last winter, the U.S. Food and Drug Administration announced Thursday. It’s a turnaround for the agency: The new recommendationContinue Reading
WEDNESDAY, June 12, 2024 (HealthDay News) — Growing public fascination with “magic” psilocybin mushrooms as a trendy treatment for depression had led to increased interest in another type of psychedelic mushroom, a new study reports. Unfortunately, this second sort of shroom — known as Amanita muscaria — can be moreContinue Reading
TUESDAY, June 11, 2024 (HealthDay News) — The U.S. Food and Drug Administration announced Monday that it has joined up with the Department of Justice and several other federal agencies to do more to stop the sale of illegal e-cigarettes in this country. In launching the newly created task force,Continue Reading
MONDAY, June 10, 2024 (HealthDay News) — The U.S. Food and Drug Administration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. Drugmaker GSK’s Arexvy vaccine, as well asContinue Reading